Abstract:Background: In recent years, tissue engineered bone by gene-modified stem cells compounded with scaffold materials in repair of bone defect has provided a novel thought for the bone tissue reconstruction. Objective: To explore the effect on repairing mandibular defect with human bone morphogenetic protein-2 (hBMP-2) gene transfected bone marrow mesenchymal stem cells (BMSCs) compounded with coral hydroxyapatite (CHA) scaffolds in osteoporotic rats. Design, time and setting: A randomized control animal experiment was completed at the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education from June 2005 to October 2006. Materials: Twenty-four unpregnant female Sprague-Dawley rats, 6 months old, SPF gradem weighing 250-300 g, were used to establish models of postmenopausal osteoporosis, The pcDNA3.1-hBMP-2 recombinant plasmid carrying hBMP-2 was offered by the Third Military Medical University of Chinese PLA; CHA scaffolds was offered by the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education. Methods: Twenty-four SD rats were divided into experimental group and control group at random, each containing 12 animals. Three months later, BMSCs harvested from osteoporotic rats were transfected by pcDNA3.1-hBMP-2 recombinant plasmid, and control group leaved untreated. Three days later, the transfected and untransfected autogenous BMSCs were seeded into CHA scaffolds, respectively. Then the cell/scaffolds composites were implanted into the critical-size defect area in the mandible bone of osteoporotic rats. Main outcome measures: At the 4th and 8th weeks after implantation, immunohistochemical analysis was performed to evaluate the new bone formation, and the amount of newly formed bone was detected semi-quantitatively at the 8th weeks. Results: All 24 SD rats were involved in the result analysis. 1 Newly formed bone was found at the margin of the defect area treated with the BMSCs modified by BMP-2 gene transfer at 4 weeks after implantation. The lamellar bone matrix was visible at 8 weeks. In the control group, only a little bone matrix was observed at the margin of CHA material at 4 weeks after implantation, however, the amount of newly formed bone was much less than the experimental group, and there was some adipose-like tissues at defect margins and central part at 8 weeks after implantation. 2 The percentage of newly formed bone area was (0.046±0.004)% and (0.233±0.015)% in the control group and the experimental group, respectively. There were significant differences in the amount of newly formed bone between two groups (P < 0.01). Conclusion: Tissue engineered bone formed by hBMP-2 gene-modified BMSCs in conjunction with CHA scaffolds, can allow large bone formation for treatment of mandibular defect in osteoporosis rats.

Enhanced bone formation of rat mandibular bone defects with collagen membranes loaded on bone morphogenetic protein-9

Evaluation of Bone Regeneration by Β Tricalcium Phosphate/Collagen Scaffold Loaded with Bone Morphogenetic Proteins 2 Plasmid in Rat Cranial Defect

Enhanced bone formation of calvarial bone defects by low-intensity pulsed ultrasound and recombinant human bone morphogenetic protein-9: a preliminary experimental study in rats

Bone regeneration using activin A/BMP2 chimera (AB204) with collagen membrane in rats with calvarial defects

Acceleration of De Novo Bone Formation with a Novel Bioabsorbable Film: a Histomorphometric Study in Vivo

Bone Regeneration of Peri-Implant Defects Using a Collagen Membrane as a Carrier for Recombinant Human Bone Morphogenetic Protein-2

Controlled Release of Bone Morphogenetic Protein-2 Augments the Coupling of Angiogenesis and Osteogenesis for Accelerating Mandibular Defect Repair

Enhanced Effects of BMP‐binding Peptide Combined with Recombinant Human BMP‐2 on the Healing of a Rodent Segmental Femoral Defect

Repair of Rat Cranial Bone Defect by Using Bone Morphogenetic Protein-2-related Peptide Combined with Microspheres Composed of Polylactic Acid/polyglycolic Acid Copolymer and Chitosan

Effect of two delivery systems for recombinant human bone morphogenetic protein-2 on periodontal regeneration in vivo

Matrigel Scaffolding Enhances BMP9-induced Bone Formation in Dental Follicle Stem/Precursor Cells.

Bone Regeneration by Rhbmp-2/Collagen in Rat Mandibular Defects

Repairing mandibular defect by gene-modified bone marrow mesenchymal stem cells combined with coral hydroxyapatite scaffold in osteoporotic rats

Accelerating Bone Generation and Bone Mineralization in the Interparietal Sutures of Rats Using an Rhbmp-2/Acs Composite after Rapid Expansion.

Enhancement of BMP-2 and VEGF carried by mineralized collagen for mandibular bone regeneration

Bone Morphogenetic Protein-9-Stimulated Adipocyte-Derived Mesenchymal Progenitors Entrapped in a Thermoresponsive Nanocomposite Scaffold Facilitate Cranial Defect Repair.

Efficacy of Bacterial Cellulose as a Carrier of BMP-2 for Bone Regeneration in a Rabbit Frontal Sinus Model

Addition of a Synthetically Fabricated Osteoinductive Biphasic Calcium Phosphate Bone Graft to BMP2 Improves New Bone Formation

Bone tissue engineering application on fracture healing with bone defect as assessed through osteocalcin and bone morphogenetic protein-2 (BMP-2) biomarker examination: experimental study on murine models

Mandibular Repair in Rats with Premineralized Silk Scaffolds and BMP-2-modified Bmscs

Low-Dose Rhbmp2/7 Heterodimer to Reconstruct Peri-Implant Bone Defects: A Micro-Ct Evaluation